This summary was created by AI, based on 1 opinions in the last 12 months.
Chemed Corporation (CHE-N) has recently been highlighted as a strong player in the healthcare sector, particularly in the hospice industry, which is experiencing significant growth. Experts note that the hospice business is growing in double-digits, indicating robust demand and expansion opportunities. The company's ability to capitalize on this trend suggests potential for continued revenue increase and enhances its overall market position. With these positive indicators, Chemed is well-poised for sustainable growth in the coming years. Overall, expert opinions reflect a favorable outlook based on the current performance and future prospects of the company.
Chemed Corporation is a American stock, trading under the symbol CHE-N on the New York Stock Exchange (CHE). It is usually referred to as NYSE:CHE or CHE-N
In the last year, 1 stock analyst published opinions about CHE-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Chemed Corporation.
Chemed Corporation was recommended as a Top Pick by on . Read the latest stock experts ratings for Chemed Corporation.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Chemed Corporation In the last year. It is a trending stock that is worth watching.
On 2025-04-01, Chemed Corporation (CHE-N) stock closed at a price of $618.56.
She added more. The hospice business is growing double-digits.